ArticleFrontiers in aging neuroscience2018
Associations of
Open access · goldAbstract read
In one paragraph
Article in Frontiers in aging neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 38 citations in OpenAlex.
- What characterizes the exceptional cognition of superagers? A systematic review of multidomain biomarkers of successful cognitive aging.The Gerontologist · 2026Pooled it
- Defining exceptional cognition in older adults: A systematic review of cognitive super-ageing.International journal of geriatric psychiatry · 2023Pooled it
- Understanding brain resilience in superagers: a systematic review.Neuroradiology · 2021Pooled it
- A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease.Alzheimer's research & therapy · 2021Trial
- Polygenic Prediction of Equestrian Sport Discipline Among Horses Bred for Jumping and Dressage.Animal genetics · 2026Article
- A harmonized framework for studying exceptional cognitive aging in Latin America.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- CK2α Overexpression in Colorectal Cancer: Evidence for Sex- and Age-Linked Differences.Cancers · 2025Article
- Sex Matters: Association with Superager Classification and Risk Factors.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025Article
- Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease.Journal of Alzheimer's disease : JAD · 2025Article
- SuperAging functional connectomics from resting-state functional MRI.Brain communications · 2024Article
- Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease.Pharmaceutics · 2023Review
- The Relative Contribution of Executive Functions and Aging on Attentional Control During Road Crossing.Frontiers in psychology · 2022Article
- Alzheimer's polygenic hazard score in SuperAgers: SuperGenes or SuperResilience?Alzheimer's & dementia (New York, N. Y.) · 2022Article
- A microRNA signature that correlates with cognition and is a target against cognitive decline.EMBO molecular medicine · 2021Article
- The Brain Metabolic Signature in Superagers Using In VivoAJNR. American journal of neuroradiology · 2021Article
- Paucity of Entorhinal Cortex Pathology of the Alzheimer's Type in SuperAgers with Superior Memory Performance.Cerebral cortex (New York, N.Y. : 1991) · 2021Article
- Don't forget-Alzheimer's & dementia (Amsterdam, Netherlands) · 2019Article
- A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction.Journal of medicinal chemistry · 2019Review
- Rediscovering the Axolotl as a Model for Thyroid Hormone Dependent Development.Frontiers in endocrinology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 2 institutions in 1 country.
Matthew J HuentelmanNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, United States.
Ignazio S PirasNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, United States.
Ashley L SiniardNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, United States.
Matthew D De BothNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, United States.
Ryan F RichholtNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, United States.
Chris D BalakNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, United States.
Pouya JamshidiCognitive Neurology & Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine (NU FSM), Chicago, IL, United States.
Eileen H BigioCognitive Neurology & Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine (NU FSM), Chicago, IL, United States.
Sandra WeintraubCognitive Neurology & Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine (NU FSM), Chicago, IL, United States.
Emmaleigh T LoyerCognitive Neurology & Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine (NU FSM), Chicago, IL, United States.
M-Marsel MesulamCognitive Neurology & Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine (NU FSM), Chicago, IL, United States.
Changiz GeulaCognitive Neurology & Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine (NU FSM), Chicago, IL, United States.
Emily J RogalskiCognitive Neurology & Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine (NU FSM), Chicago, IL, United States.
Northwestern University · USTranslational Genomics Research Institute · US
Funding
Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0MNational Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8MNeuropathology CoreP30AG013854 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VASSAR, ROBERT J · 1996 to 2020
$28.9MPREDOCTORAL AND POSTDOCTORAL TRAINING PROGRAM IN AGING AND DEMENTIAT32AG020506 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROBERT J VASSAR, SANDRA WEINTRAUB · 2002 to 2026
$9.9MSYNAPTIC SUBSTRATES OF AGE-DEPENDENT MEMORY DEFICITSR01AG017139 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DISTERHOFT, JOHN F · 1999 to 2013
$4.6MExceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic CorrelatesR01AG045571 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GEULA, CHANGIZ, MESULAM, MAREK-MARSEL M · 2014 to 2019
$2.6MNIA NIH HHS P30 AG013854NIA NIH HHS R01 AG017139NIA NIH HHS R01 AG045571NIA NIH HHS T32 AG020506NIA NIH HHS U01 AG024904NIA NIH HHS U24 AG021886
Abstract
PubMed holds no abstract for this paper.
Indexed as
agingAlzheimer’sAlzheimer’s dementiaAlzheimer’s disease (AD)cognitionepisodic memorygeneticssuccessful agingwhole exome sequencing
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.